000			02227 a2200601 4500
005			20250517234231.0
264		0	_c20190114
008			201901s 0 0 eng d
022			_a1744-8069
024	7		_a10.1177/1744806918801224 _2doi
040			_aNLM _beng _cNLM
100	1		_aLee, Wan-Hung
245	0	0	_aZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability. _h[electronic resource]
260			_bMolecular pain _c
300			_a1744806918801224 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdaptor Proteins, Signal Transducing _xantagonists & inhibitors
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCerebral Cortex _xcytology
650	0	4	_aDisease Models, Animal
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGreen Fluorescent Proteins _xgenetics
650	0	4	_aHEK293 Cells
650	0	4	_aHumans
650	0	4	_aHyperalgesia _xdrug therapy
650	0	4	_aImmunoprecipitation
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aNeuralgia _xchemically induced
650	0	4	_aNeurons
650	0	4	_aNitric Oxide Synthase Type I _xantagonists & inhibitors
650	0	4	_aPaclitaxel _xadverse effects
650	0	4	_aPain Threshold _xdrug effects
650	0	4	_aRats
650	0	4	_aTransfection
650	0	4	_aXenograft Model Antitumor Assays _xmethods
700	1		_aCarey, Lawrence M
700	1		_aLi, Li-Li
700	1		_aXu, Zhili
700	1		_aLai, Yvonne Y
700	1		_aCourtney, Michael J
700	1		_aHohmann, Andrea G
773	0		_tMolecular pain _gvol. 14 _gp. 1744806918801224
856	4	0	_uhttps://doi.org/10.1177/1744806918801224 _zAvailable from publisher's website
999			_c28778887 _d28778887